Key facts
- This page summarizes Third Rock Ventures III, L.P.'s Form 4 filing for Jounce Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Nov 2021, 18:57.
Third Rock Ventures III, L.P. - 12 Nov 2021 Form 4 Insider Report for Jounce Therapeutics, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 12 Nov 2021
- Net transaction value
- -$15,922,000
- SEC form
- 4
- Accepted by SEC
- 16 Nov 2021, 18:57:50 UTC
- Prior SEC filing
- 12 Nov 2021
- Next SEC filing
- 10 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Gillis, Chief Operating Officer of TRV GP III, LLC, general partner of Third Rock Ventures GP III, L.P., general partner of Third Rock Ventures III, L.P.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Third Rock Ventures III, L.P. filed Form 4 for Jounce Therapeutics, Inc. on 16 Nov 2021.
Change
- Previous filing in this sequence was filed on 12 Nov 2021.
- Current net transaction value: -$15,922,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JNCE
transaction
Common Stock
Sale
- Transaction value
- $15,922,000
- Shares
- -1,900,000
- Change %
- -62%
- Price
- $8.38
- Shares after
- 1,148,780
- Date
- 12 Nov 2021
- Ownership
- Direct
- Footnotes
- F1, F2
JNCE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,697,829
- Date
- 12 Nov 2021
- Ownership
- See footnote
- Footnotes
- F3
JNCE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 284,344
- Date
- 12 Nov 2021
- Ownership
- See footnote
- Footnotes
- F4
JNCE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 283,850
- Date
- 12 Nov 2021
- Ownership
- See footnote
- Footnotes
- F5
JNCE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 283,858
- Date
- 12 Nov 2021
- Ownership
- See footnote
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $8.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F2
These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
Footnote F3
These shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II"). The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Levin, Starr and Tepper. Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
Footnote F4
The shares are directly held by Levin.
Footnote F5
The shares are directly held by Starr.
Footnote F6
The shares are directly held by Tepper.